This is the authors' abstract. We don't add key points for this paper.
In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hunsawong et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: